Farallon Capital Management
http://www.faralloncapital.com/farallon/index.htmFarallon Capital Management is an investment firm than manages equity capital for institutions and high net worth individuals. The firm's institutional investors are primarily college endowments and foundations. Farallon primarily invests in businesses and securities that are undergoing change or will appreciate because of an expected event which includes mergers, restructurings, recapitalizations or other major changes. The firm seeks to build strong relationships with the management of companies in which it invests.
View Older Stories View More Recent Stories
-
Form SC 13G/A Disruptive Acquisition Filed by: Farallon Capital Partners, L.P.
-
Form SC 13G/A ARYA Sciences Acquisitio Filed by: Farallon Capital Partners, L.P.
-
Japan's Fuji Soft in talks over possible private equity buyouts
-
Form SC 13G NEW YORK TIMES CO Filed by: Farallon Capital Partners, L.P.
-
Mach Natural Resources Completes the Acquisition of Paloma Anadarko Basin Assets
-
Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
-
Grosvenor's North American Property Business Announces Investment Team Leadership Changes
-
Zambia External Bondholder Steering Committee Statement regarding OCC stance on Comparability of Treatment
-
Salesforce's strong stock price wooed some investors during third quarter - filings
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Dec 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Sep 30
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Form 13F-NT Farallon Capital Europe For: Sep 30
-
Mach Natural Resources Adds Accretive Acquisition in Anadarko Basin
-
/C O R R E C T I O N -- Mach Natural Resources/
-
Form SC 13G Revolution Medicines, Filed by: Farallon Capital Partners, L.P.
-
Form SC 13G AGIOS PHARMACEUTICALS, Filed by: Farallon Capital Partners, L.P.
-
Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Jun 30
-
Zambia External Bondholder Steering Committee Reaches Agreement in Principle with Zambia on Debt Restructuring
-
Kate Bassett Joins Galvanize Climate Solutions As Vice President
-
Form SC 13G Aramark Filed by: Farallon Capital Partners, L.P.
-
Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
-
Form SC 13G Beam Therapeutics Inc. Filed by: Farallon Capital Partners, L.P.
-
Mid-Market HR Tech Leader HiBob Adds $150M in New Round of Funding to Support Continued Expansion
-
Toshiba's top investor to sell stake in JIP offer, source says
-
Galvanize Climate Solutions Closes Over $1 Billion for First Venture and Growth Equity Fund
-
Fin Capital Appoints Nicholas Cirella as General Counsel and Chief Compliance Officer
-
Paratus Energy Services Ltd. - Appointment of Joachim Bale to the Board
-
Beta Bionics Secures $100 Million in Series D Funding to Advance Diabetes Technology and Expand Market Presence
-
AUNA APPOINTS ANASOFIA SANCHEZ JUAREZ TO ITS BOARD OF DIRECTORS
-
Activists back off Salesforce after share price recovery
-
Form 13F-HR/A FARALLON CAPITAL MANAGEM For: Mar 31
-
Form 13F-NT Farallon Capital Europe For: Jun 30
-
Form 13F-HR FARALLON CAPITAL MANAGEM For: Jun 30
-
Form SC 13D CHINOOK THERAPEUTICS, Filed by: Farallon Capital Partners, L.P.
-
Form SC 13G Forte Biosciences, Inc. Filed by: Farallon Capital Partners, L.P.
-
Forte Biosciences (FBRX) Announces $25M Financing and R&D Update for FB-102
-
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
-
Farallon Capital Management Closes Fourth Real Estate Fund with over $650 Million in Aggregate Investor Commitments
-
Form D/A Farallon Capital F5 Inve
-
Form D/A Farallon Capital F5 Inve
-
Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.
-
Form SC 13D/A EXELIXIS, INC. Filed by: Farallon Capital Partners, L.P.
-
Farallon Capital Management Comments on Election of All Three of Its Nominees to Exelixis’ Board
-
Form SC 13D/A Cazoo Group Ltd Filed by: Farallon Capital Partners, L.P.

